George Pentheroudakis holds an MD degree from the Aristotle University of Thessaloniki and a PhD degree from the University of Ioannina, Greece. He specialised in Internal Medicine in Thessaloniki, Greece (1993-1999), subsequently held a National Training Number in Medical Oncology at the Beatson Oncology Centre, Glasgow, United Kingdom (1999-2002). He currently serves as Associate Professor of Oncology at the Medical School, University of Ioannina, Greece, where he is the Head of the Department of Medical Oncology. He also serves as Coordinator of the Hellenic Cooperative Oncology Group (HeCOG) Gastrointestinal Working Group.
He is actively involved in translational research and phase I-II studies evaluating novel agents targeting membrane receptors, cell signalling pathways, immune response and angiogenesis. His main research interests are gastrointestinal cancer, cancer of unknown primary, neuroendocrine tumours and drug development in early phase trials. He currently develops a program devoted to the detection and genotyping of circulating cell-free DNA, RNA.
Dr. Pentheroudakis served as co-chair (2012-2014) and currently as Chair of the ESMO Guidelines Committee and is a member of the Executive Board of the European Society for Medical Oncology (ESMO, 2016-2017) and the ESMO CUP and Endocrine Tumour Faculty. He is a member of the American Society of Clinical Oncology (ASCO) and is involved in different editorial boards including Cancers, Cancer Treatment Communications, EJSO – European Journal of Surgical Oncology, Rare Cancers and Therapy. He has (co)authored 235 PubMed-indexed peer-reviewed papers and speaks English, French.